Find Federal Grants
National Institutes of Health · RFA-DA-20-011
National Institutes of Health · RFA-DA-20-012
National Institutes of Health · PAR-19-275
National Institutes of Health · PAR-19-277
National Institutes of Health · PAR-19-274
Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed)
National Institutes of Health · PAR-19-276
PHS 2019-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required
National Institutes of Health · PA-19-273
PHS 2019-02 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Not Allowed
National Institutes of Health · PA-19-270
PHS 2019-02 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Required
National Institutes of Health · PA-19-271
PHS 2019-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed
National Institutes of Health · PA-19-272
National Aeronautics and Space Administration · NNH19ZHA002N
National Park Service · P19AS00144
National Park Service · P19AS00143
Bureau of Indian Affairs · BIE-0002
Fiscal Year (FY) 2019 National Earthquake Hazards Reduction Program (NEHRP), Earthquake Consortium and Partner Support (ECPS)
Department of Homeland Security - FEMA · DHS-19-MT-082-00-01
Office of Elementary and Secondary Education (OESE): Jacob K. Javits Gifted and Talented Students Education (Javits) Program CFDA Number 84.206A
Department of Education · ED-GRANTS-050319-002
Office of Elementary and Secondary Education (OESE): Comprehensive Literacy State Development (CLSD) Program CFDA Number 84.371C
Department of Education · ED-GRANTS-050319-001
HLA and KIR Region Genomics in Immune-Mediated Diseases (U01 Clinical Trial Not Allowed)
National Institutes of Health · RFA-AI-19-041
Imaging, Biomarkers and Digital Pathomics for the Early Detection of Premetastatic Aggressive Cancer (R01 Clinical Trial Optional)
National Institutes of Health · PAR-19-264
National Institutes of Health · PAR-19-262